|
Market Closed -
Nasdaq
16:00:00 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 138.36 USD | +0.16% |
|
+3.87% | +12.73% |
| 08-11 | Global drugmakers invest billions to boost US presence | RE |
| 08-11 | Nucleai And Gilead Sciences Advance AI-Powered Tissue Intelligence Through Large-Scale Oncology ADC Collaboration | CI |
| Market Cap | 172B 148B 139B 127B 238B 16,405B 242B 1,631B 638B 8,215B 644B 630B 27,300B | P/E 2026 * |
-42.3x | P/E 2027 * | 17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 188B 163B 153B 139B 261B 18,006B 266B 1,791B 700B 9,017B 707B 692B 29,964B | EV / Sales 2026 * |
6.13x | EV / Sales 2027 * | 5.53x |
| Free-Float |
99.88% | Yield 2026 * |
2.38% | Yield 2027 * | 2.45% |
Last Transcript: Gilead Sciences, Inc.
| 1 day | +0.16% | ||
| 1 week | +3.87% | ||
| Current month | +6.26% | ||
| 1 month | +5.06% | ||
| 3 months | +6.78% | ||
| 6 months | -10.72% | ||
| Current year | +12.73% |
| 1 week | 131.61 |  | 138.43 |
| 1 month | 127.61 | | 140.61 |
| Current year | 116.88 | | 157.29 |
| 1 year | 108.46 | | 157.29 |
| 3 years | 62.07 | | 157.29 |
| 5 years | 57.16 | | 157.29 |
| 10 years | 56.56 | | 157.29 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel O'Day
CEO | Chief Executive Officer | 61 | 2019-02-28 |
Andrew Dickinson
DFI | Director of Finance/CFO | 56 | 2019-10-31 |
Keeley Wettan
CMP | Compliance Officer | - | 2025-12-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Kelly Kramer
BRD | Director/Board Member | 58 | 2016-08-18 |
| Director/Board Member | 73 | 2017-12-31 | |
Harish Manwani
BRD | Director/Board Member | 72 | 2018-05-08 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/10/26 | Fiscal year | EVP Gen Counsel, Legal & Comp | 14,912 | 0.0012% | ||
| 8/3/26 | Sell | Chief Executive Officer | -15,000 | 0.0012% | ||
| 7/15/26 | Sell | Executive/Senior Manager | -3,000 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.16% | +3.87% | +16.89% | +73.73% | 172B | |
| -2.25% | -0.47% | +68.30% | +115.90% | 1,052B | |
| -0.66% | +0.43% | +47.39% | +50.54% | 627B | |
| -0.54% | +1.39% | +20.69% | +63.99% | 441B | |
| -1.99% | -3.32% | +38.71% | +35.41% | 349B | |
| -1.05% | -2.81% | +23.07% | +35.70% | 287B | |
| -2.12% | -3.67% | -1.14% | +5.37% | 241B | |
| -0.63% | +1.04% | +40.05% | +56.09% | 224B | |
| -1.19% | -3.41% | -9.57% | -52.71% | 202B | |
| -0.04% | +0.11% | +6.56% | -24.30% | 153B | |
| Average | -1.03% | +0.62% | +25.10% | +35.97% | 374.79B | |
| Weighted average by Cap. | -1.30% | +0.40% | +37.76% | +57.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30.71B 26.52B 24.92B 22.66B 42.61B 2,936B 43.31B 292B 114B 1,470B 115B 113B 4,886B | 32.7B 28.24B 26.54B 24.13B 45.37B 3,126B 46.12B 311B 122B 1,566B 123B 120B 5,203B |
| Net income | -4.27B -3.69B -3.47B -3.16B -5.93B -409B -6.03B -40.65B -15.89B -205B -16.05B -15.7B -680B | 10.28B 8.87B 8.34B 7.58B 14.26B 983B 14.49B 97.71B 38.2B 492B 38.58B 37.74B 1,635B |
| Net Debt | 16.75B 14.46B 13.59B 12.36B 23.24B 1,601B 23.62B 159B 62.26B 802B 62.87B 61.51B 2,665B | 9.12B 7.88B 7.41B 6.73B 12.66B 873B 12.87B 86.77B 33.93B 437B 34.26B 33.51B 1,452B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-14 | US$138.36 | +0.16% | 3,407,825 |
| 26-08-13 | US$138.14 | +1.67% | 4,897,034 |
| 26-08-12 | US$135.87 | +0.07% | 5,683,968 |
| 26-08-11 | US$135.77 | +2.04% | 5,493,691 |
| 26-08-10 | US$133.06 | -0.11% | 6,833,770 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GILD Stock
Select your edition
All financial news and data tailored to specific country editions
